• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

枸橼酸西地那非(万艾可)改善老年勃起功能障碍患者的勃起功能:一项亚组分析。

Sildenafil citrate (VIAGRA) improves erectile function in elderly patients with erectile dysfunction: a subgroup analysis.

作者信息

Wagner G, Montorsi F, Auerbach S, Collins M

机构信息

University of Copenhagen, Division of Sexual Physiology, Rigshospitalet, Denmark.

出版信息

J Gerontol A Biol Sci Med Sci. 2001 Feb;56(2):M113-9. doi: 10.1093/gerona/56.2.m113.

DOI:10.1093/gerona/56.2.m113
PMID:11213274
Abstract

BACKGROUND

The prevalence of erectile dysfunction (ED) increases with advancing age, with a particularly high prevalence of ED in elderly patients with diabetes. In the United States it is estimated that approximately 45% of men aged 65 to 69 years have moderate or complete ED. The efficacy and safety of oral sildenafil (VIAGRA) for treating ED in elderly men (aged > or = 65 years or older) were assessed.

METHODS

We analyzed data obtained from five double-blind, placebo-controlled studies of the efficacy and tolerability of oral sildenafil taken as required (but not more than once daily) over a 12-week to 6-month period. Two subgroups were evaluated: (i) elderly patients with ED of broad-spectrum etiology (n = 411), and (ii) elderly patients with ED and diabetes (n = 71). Efficacy was assessed using a global efficacy question, questions 3 and 4 of the International Index of Erectile Function (IIEF). and the five sexual function domains of the IIEF.

RESULTS

All efficacy assessments indicated that sildenafil significantly improved erectile function both in elderly patients with ED of broad-spectrum etiology and in elderly patients with ED and diabetes. The most common adverse events were mild-to-moderate headache, flushing, and dyspepsia. The rates of discontinuation due to adverse events were low and were comparable to the rates with placebo.

CONCLUSIONS

Sildenafil is an efficacious and well-tolerated treatment for ED in elderly men.

摘要

背景

勃起功能障碍(ED)的患病率随年龄增长而增加,糖尿病老年患者中ED的患病率尤其高。在美国,据估计65至69岁的男性中约45%患有中度或完全性ED。评估了口服西地那非(伟哥)治疗老年男性(年龄≥65岁)ED的疗效和安全性。

方法

我们分析了从五项双盲、安慰剂对照研究中获得的数据,这些研究涉及按需服用(但每日不超过一次)口服西地那非12周至6个月的疗效和耐受性。评估了两个亚组:(i)病因广泛的老年ED患者(n = 411),以及(ii)患有ED和糖尿病的老年患者(n = 71)。使用总体疗效问题、国际勃起功能指数(IIEF)的问题3和问题4以及IIEF的五个性功能领域来评估疗效。

结果

所有疗效评估均表明,西地那非在病因广泛的老年ED患者以及患有ED和糖尿病的老年患者中均显著改善了勃起功能。最常见的不良事件是轻度至中度头痛、潮红和消化不良。因不良事件停药的发生率较低,且与安慰剂组相当。

结论

西地那非是治疗老年男性ED的一种有效且耐受性良好的药物。

相似文献

1
Sildenafil citrate (VIAGRA) improves erectile function in elderly patients with erectile dysfunction: a subgroup analysis.枸橼酸西地那非(万艾可)改善老年勃起功能障碍患者的勃起功能:一项亚组分析。
J Gerontol A Biol Sci Med Sci. 2001 Feb;56(2):M113-9. doi: 10.1093/gerona/56.2.m113.
2
Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials.枸橼酸西地那非用于患有糖尿病和心血管危险因素男性的勃起功能障碍:来自安慰剂对照试验汇总数据的回顾性分析
Curr Med Res Opin. 2006 Nov;22(11):2111-20. doi: 10.1185/030079906X148256.
3
Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease.枸橼酸西地那非治疗缺血性心脏病患者勃起功能障碍的疗效与安全性。
Am J Cardiol. 1999 Mar 4;83(5A):29C-34C. doi: 10.1016/s0002-9149(99)00045-4.
4
Erectile function and assessments of erection hardness correlate positively with measures of emotional well-being, sexual satisfaction, and treatment satisfaction in men with erectile dysfunction treated with sildenafil citrate (Viagra).对于接受枸橼酸西地那非(万艾可)治疗的勃起功能障碍男性患者,勃起功能及勃起硬度评估与情绪健康、性满意度和治疗满意度指标呈正相关。
Urology. 2006 Sep;68(3 Suppl):26-37. doi: 10.1016/j.urology.2006.06.027.
5
The efficacy of sildenafil citrate (Viagra) in clinical populations: an update.枸橼酸西地那非(万艾可)在临床人群中的疗效:最新进展。
Urology. 2002 Sep;60(2 Suppl 2):12-27. doi: 10.1016/s0090-4295(02)01687-4.
6
Efficacy and safety of sildenafil citrate (Viagra) in black and Hispanic American men.枸橼酸西地那非(万艾可)在非裔美国男性和西班牙裔美国男性中的疗效与安全性。
Urology. 2002 Sep;60(2 Suppl 2):39-48. doi: 10.1016/s0090-4295(02)01689-8.
7
Long-term efficacy and safety of oral Viagra (sildenafil citrate) in men with erectile dysfunction and the effect of randomised treatment withdrawal.口服万艾可(枸橼酸西地那非)对勃起功能障碍男性的长期疗效与安全性及随机撤药的影响
Int J Impot Res. 2000 Jun;12(3):177-82. doi: 10.1038/sj.ijir.3900527.
8
ASSESS-3: a randomised, double-blind, flexible-dose clinical trial of the efficacy and safety of oral sildenafil in the treatment of men with erectile dysfunction in Taiwan.ASSESS - 3:一项关于口服西地那非治疗台湾勃起功能障碍男性疗效与安全性的随机、双盲、灵活剂量临床试验。
Int J Impot Res. 2001 Aug;13(4):221-9. doi: 10.1038/sj.ijir.3900685.
9
Sildenafil citrate (Viagra) is effective and well tolerated for treating erectile dysfunction of psychogenic or mixed aetiology.枸橼酸西地那非(万艾可)治疗心因性或混合性病因引起的勃起功能障碍有效且耐受性良好。
Int J Clin Pract. 2000 Nov;54(9):561-6.
10
Sildenafil citrate (Viagra) in erectile dysfunction: near normalization in men with broad-spectrum erectile dysfunction compared with age-matched healthy control subjects.枸橼酸西地那非(万艾可)治疗勃起功能障碍:与年龄匹配的健康对照受试者相比,广谱勃起功能障碍男性患者的勃起功能接近正常。
Urology. 1999 Apr;53(4):800-5. doi: 10.1016/s0090-4295(98)00586-x.

引用本文的文献

1
A multicenter, randomized, open-labeled, parallel group trial of sildenafil in alcohol-associated erectile dysfunction: the impact on psychosocial outcomes.多中心、随机、开放标签、平行组试验研究西地那非治疗酒精相关性勃起功能障碍:对心理社会结局的影响。
Int J Environ Res Public Health. 2009 Sep;6(9):2510-25. doi: 10.3390/ijerph6092510. Epub 2009 Sep 23.
2
Effect of repeated doses of darunavir plus low-dose ritonavir on the pharmacokinetics of sildenafil in healthy male subjects: phase I randomized, open-label, two-way crossover study.重复剂量的达芦那韦联合低剂量利托那韦对健康男性受试者西地那非药代动力学的影响:I期随机、开放标签、双向交叉研究。
Clin Drug Investig. 2008;28(8):479-85. doi: 10.2165/00044011-200828080-00002.
3
Sildenafil in the treatment of erectile dysfunction: an overview of the clinical evidence.
西地那非治疗勃起功能障碍:临床证据综述
Clin Interv Aging. 2006;1(4):403-14. doi: 10.2147/ciia.2006.1.4.403.
4
Four-year review of sildenafil citrate.枸橼酸西地那非的四年回顾
Rev Urol. 2002;4 Suppl 3(Suppl 3):S26-38.
5
Optimizing outcomes of oral therapy for patients with erectile dysfunction.优化勃起功能障碍患者口服治疗的效果。
Rev Urol. 2003;5 Suppl 7(Suppl 7):S28-34.
6
A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient?勃起功能障碍治疗方案的比较性综述:何种治疗适用于何种患者?
Drugs. 2005;65(12):1621-50. doi: 10.2165/00003495-200565120-00003.
7
Men's aging and sexual disorders: an update on diagnosis and treatment.
Rev Endocr Metab Disord. 2005 May;6(2):85-92. doi: 10.1007/s11154-005-6720-y.
8
Safety and tolerability of oral erectile dysfunction treatments in the elderly.老年人口服勃起功能障碍治疗药物的安全性和耐受性。
Drugs Aging. 2005;22(4):323-38. doi: 10.2165/00002512-200522040-00005.